RxSight, Inc. to Present at the Bank of America Healthcare Conference
02 5월 2024 - 5:05AM
RxSight, Inc., an ophthalmic medical device company dedicated to
providing high-quality customized vision to patients following
cataract surgery, today announced plans to participate in the
upcoming Bank of America Healthcare Conference.
RxSight’s management is scheduled to present on Wednesday, May
15, 2024, at 10:00 a.m. Pacific Time / 1:00 p.m. Eastern Time.
Interested parties may access a live and archived webcast of the
presentation at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated
to providing high-quality customized vision to patients following
cataract surgery. The RxSight® Light Adjustable Lens system,
comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+™),
RxSight Light Delivery Device (LDD™) and accessories, is the first
and only commercially available intraocular lens (IOL) technology
that can be adjusted after surgery, enabling doctors to customize
and deliver high-quality vision to patients after cataract surgery.
Additional information about RxSight can be found
at www.rxsight.com.
Company Contact:Shelley B. ThunenChief
Financial Officersthunen@rxsight.com
Investor Relations Contact:Oliver MoravcevicVP,
Investor Relationsomoravcevic@rxsight.com
RxSight (NASDAQ:RXST)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
RxSight (NASDAQ:RXST)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
